• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于结构的虚拟筛选鉴定多种天然产物作为疟原虫蛋白酶-2抑制剂。

Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.

作者信息

Wang Liyan, Zhang Shoude, Zhu Junsheng, Zhu Lili, Liu Xiaofeng, Shan Lei, Huang Jin, Zhang Weidong, Li Honglin

机构信息

Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.

Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.

出版信息

Bioorg Med Chem Lett. 2014 Mar 1;24(5):1261-4. doi: 10.1016/j.bmcl.2014.01.074. Epub 2014 Feb 2.

DOI:10.1016/j.bmcl.2014.01.074
PMID:24530004
Abstract

Ten natural compounds are successfully identified as falcipain-2 (FP-2) inhibitors from our in-house natural products database using structure-based virtual screening, which show moderate inhibitory activities against FP-2 with IC50 values ranging from 3.18 to 68.19 μM. While one of the inhibitors (compound 5) also exhibits in vitro antiplasmodial activity against chloroquine sensitive strain (3D7) and chloroquine resistant strain (Dd2) of Plasmodium falciparum in the micromolar range (IC50s=5.54 μM and 4.05 μM against 3D7 cells and Dd2 cells, respectively). Furthermore, the predicted binding poses are analyzed to explain the structure-activity relationships, which will be helpful for further structural modifications.

摘要

通过基于结构的虚拟筛选,从我们内部的天然产物数据库中成功鉴定出10种天然化合物作为疟原虫蛋白酶-2(FP-2)抑制剂,它们对FP-2显示出中等抑制活性,IC50值范围为3.18至68.19μM。其中一种抑制剂(化合物5)在微摩尔范围内(对3D7细胞和Dd2细胞的IC50分别为5.54μM和4.05μM)对恶性疟原虫的氯喹敏感株(3D7)和氯喹耐药株(Dd2)也表现出体外抗疟原虫活性。此外,对预测的结合模式进行分析以解释构效关系,这将有助于进一步的结构修饰。

相似文献

1
Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.通过基于结构的虚拟筛选鉴定多种天然产物作为疟原虫蛋白酶-2抑制剂。
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1261-4. doi: 10.1016/j.bmcl.2014.01.074. Epub 2014 Feb 2.
2
Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2.噻唑烷二酮类化合物作为恶性疟原虫半胱氨酸蛋白酶 falcipain-2 的抗疟抑制剂的合成及构效关系研究。
Eur J Med Chem. 2015 Jan 27;90:507-18. doi: 10.1016/j.ejmech.2014.11.061. Epub 2014 Dec 2.
3
Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.鉴定新型疟原虫蛋白酶-2抑制剂作为潜在抗疟药物
Bioorg Med Chem. 2015 May 1;23(9):2221-40. doi: 10.1016/j.bmc.2015.02.062. Epub 2015 Mar 18.
4
Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.合成鸡蛋白氨酸酰胺 A 类似物作为有效的疟原虫蛋白酶抑制剂和抗疟药物。
J Med Chem. 2014 Dec 26;57(24):10557-63. doi: 10.1021/jm501439w. Epub 2014 Dec 8.
5
Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.鉴定具有双重疟原虫蛋白酶 2 和疟原虫蛋白酶 3 抑制活性的抗疟先导化合物。
Bioorg Med Chem. 2020 Jan 1;28(1):115155. doi: 10.1016/j.bmc.2019.115155. Epub 2019 Nov 9.
6
Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.基于计算的虚拟筛选:通过靶向疟原虫蛋白酶III设计新型抗疟药物——一种基于结构的药物设计方法
J Vector Borne Dis. 2013 Apr-Jun;50(2):93-102.
7
Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.鉴定(4-(9H-芴-9-基)哌嗪-1-基)甲酮衍生物作为疟原虫 2 抑制剂对恶性疟原虫培养物的活性。
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2911-2923. doi: 10.1016/j.bbagen.2018.09.015. Epub 2018 Sep 22.
8
Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.新型抗疟药的发现:通过片段组装针对FP-2和PfDHFR的第二代双重抑制剂
Bioorg Med Chem. 2017 Dec 15;25(24):6467-6478. doi: 10.1016/j.bmc.2017.10.017. Epub 2017 Oct 16.
9
Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.基于结构的靶向半胱氨酸蛋白酶抑制剂文库虚拟筛选鉴定新型疟原虫半胱氨酸蛋白酶抑制剂
J Chem Inf Model. 2011 Apr 25;51(4):852-64. doi: 10.1021/ci200029y. Epub 2011 Mar 23.
10
Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.哒嗪并[1,2-a]嘧啶-4-酮类作为抗疟原虫 falcipain-2 抑制剂。
Bioorg Med Chem. 2012 Nov 1;20(21):6296-304. doi: 10.1016/j.bmc.2012.09.008. Epub 2012 Sep 13.

引用本文的文献

1
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?三十年靶向疟原虫裂殖体蛋白研发抗疟药物:我们从中得到了哪些启示,下一步该怎么做?
Curr Med Chem. 2024;31(16):2234-2263. doi: 10.2174/0929867331666230913165219.
2
Target-Based Virtual Screening of Natural Compounds Identifies a Potent Antimalarial With Selective Falcipain-2 Inhibitory Activity.基于靶点的天然化合物虚拟筛选鉴定出一种具有选择性抑制疟原虫蛋白酶-2活性的强效抗疟药。
Front Pharmacol. 2022 Apr 6;13:850176. doi: 10.3389/fphar.2022.850176. eCollection 2022.
3
South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches.
南非松香烷二萜类化合物及其类似物作为潜在的抗疟药物:来自杂交计算方法的新见解。
Molecules. 2019 Nov 7;24(22):4036. doi: 10.3390/molecules24224036.
4
Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.导向性药物再利用:恶性疟原虫蛋白酶-2新型竞争性和非竞争性抑制剂的发现
Front Chem. 2019 Aug 6;7:534. doi: 10.3389/fchem.2019.00534. eCollection 2019.
5
Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational Perspective.中药与复杂疾病的生物网络:计算视角
Evid Based Complement Alternat Med. 2017;2017:7198645. doi: 10.1155/2017/7198645. Epub 2017 Jun 11.
6
Three-dimensional (3D) structure prediction of the American and African oil-palms β-ketoacyl-[ACP] synthase-II protein by comparative modelling.通过比较建模对美洲油棕和非洲油棕β-酮脂酰-[酰基载体蛋白]合酶-II蛋白进行三维(3D)结构预测。
Bioinformation. 2014 Mar 19;10(3):130-7. doi: 10.6026/97320630010130. eCollection 2014.